Skip to content

Evaluation of the Peritoneal Dialysis Program in a Hospital in Chinandega, Nicaragua.

Evaluation of the Peritoneal Dialysis Program in a Hospital in Chinandega, Nicaragua.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02270229
Enrollment
60
Registered
2014-10-21
Start date
2014-11-30
Completion date
Unknown
Last updated
2014-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease, Peritoneal Dialysis

Brief summary

The purpose of this study is to develop recommendations to assist in improving the current peritoneal dialysis (PD) program in a Hospital in Chinandega, Nicaragua. This project will consist of a needs assessment, a review of aggregate quantitative patient data from hospital records, and a knowledge, attitudes, and practices (KAP) assessment for medical providers, laboratory technicians, patients and primary caregivers. The final report will be used to obtain funding for the implementation of the recommendations.

Interventions

None listed

Sponsors

Baxter Healthcare Corporation
CollaboratorINDUSTRY
La Isla Foundation
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1\. Participants must be affiliated with the PD program that is under evaluation

Exclusion criteria

1. Being physically unable to participate in an interview of approximately one hour 2. Being younger than 18 years of age 3. Refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Identification of needs of the PD programHospital visits for the duration of 1 weekThis outcome will be measured by filling out a pre-designed checklist based on national and international guidelines, including equipment, material and staffing needs.
Adherence to established protocols on administering PD treatment in the hospital3 days of observation sessions for the duration of 8 hoursThis outcome will be measured by filling out a validated checklist of steps that need to be performed by the healthcare provider while PD is administered in the Hospital
Levels of knowledge, attitudes and practices towards PD of healthcare providers, laboratory staff patients and primary caregiversInterviews of each group for the duration of 1 weekThis outcome will be measured by administering a questionnaire to the participants of 4 respective groups (healthcare providers, laboratory staff, patients, primary caregivers). The questionnaire will contain sections on (1) demographic information/professional affiliation with the program, (2) knowledge of PD, (3) attitudes towards PD, (4) practices regarding PD, and (5) perceived needs of the program. The levels of knowledge will be classified in four categories: 1) very good, 2) good, 3) regular, 4) poor. Attitudes will be classified as either positive or negative. Practices will be classified as either good or bad.
Prevalence of peritonitis and causative agentsSample collections according to PD patients' appointment times during one week and culturing of samples for 72 hoursThis outcome will be measured by identifying pathogens in patients' dialysate liquid and estimating the overall percentage of patients with peritonitis.

Contacts

Primary ContactDorien Faber, MSc.
dorien@laislafoundation.org+505 2315 1261
Backup ContactPurvi Patel, JD.
purvi@laislafoundation.org+505 2315 1261

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026